Company Data
Tempest Therapeutics Inc.
Ticker
TPST
Current Price
$0.6242 -1.7%
Market Cap
$10.3M
Price Target
Refer to Report
Volume
66.1K
52wk Range
$0.6203 - $12.23
Overview
Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.